BNXT.CN Stock - BioNxt Solutions Inc.
Unlock GoAI Insights for BNXT.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $26,985 | $372,247 | $297,442 | $286,498 | $345,654 |
| Gross Profit | $26,985 | $372,247 | $195,615 | $199,478 | $345,654 |
| Gross Margin | 100.0% | 100.0% | 65.8% | 69.6% | 100.0% |
| Operating Income | $-4,449,274 | $-6,367,309 | $-6,044,928 | $-16,310,050 | $-14,972,179 |
| Net Income | $-5,311,505 | $-7,722,927 | $-12,376,071 | $-20,637,104 | $-16,889,762 |
| Net Margin | -19683.2% | -2074.7% | -4160.8% | -7203.2% | -4886.3% |
| EPS | $-0.05 | $-0.08 | $-0.15 | $-0.29 | $-0.30 |
BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, thin film drug formulation, and psychedelic pharmaceutical production and formulation businesses. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Visit WebsiteEarnings History & Surprises
BNXT.CNEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 28, 2025 | — | $-0.01 | — | — |
Q2 2025 | Jun 20, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 29, 2025 | — | $-0.02 | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.01 | — | — |
Q4 2024 | Nov 1, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 30, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 30, 2024 | — | $-0.01 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.02 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.02 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.02 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.14 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.03 | — | — |
Q3 2022 | Aug 26, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.03 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.11 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.04 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.06 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.08 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.04 | — | — |
Latest News
Frequently Asked Questions about BNXT.CN
What is BNXT.CN's current stock price?
What is the analyst price target for BNXT.CN?
What sector is BioNxt Solutions Inc. in?
What is BNXT.CN's market cap?
Does BNXT.CN pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BNXT.CN for comparison